Clinical Trials Directory

Trials / Conditions / Ureteral Neoplasms

Ureteral Neoplasms

7 registered clinical trials studyying Ureteral Neoplasms — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingFORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
NCT05614739
Eli Lilly and CompanyPhase 1
TerminatedA Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer
NCT03288545
Astellas Pharma Global Development, Inc.Phase 1 / Phase 2
CompletedA Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
NCT03219333
Astellas Pharma IncPhase 2
TerminatedLCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer
NCT02612194
Wake Forest University Health SciencesPhase 2
SuspendedLymphadenectomy in Urothelial Carcinoma
NCT02607709
Zealand University HospitalN/A
CompletedTRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma
NCT01328574
National Cancer Institute (NCI)Phase 2
CompletedTOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Uroth
NCT00077688
Achieve Life SciencesPhase 2